Ryan Zimmerman
Stock Analyst at BTIG
(4.27)
# 1,456
Out of 5,118 analysts
1443
Total ratings
49.7%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Reiterated: Buy | $15 → $21 | $16.59 | +26.58% | 59 | Nov 6, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $27 | $20.54 | +31.45% | 8 | Nov 6, 2026 | |
| SOLV Solventum | Reiterated: Buy | $95 → $100 | $90.38 | +10.64% | 25 | Nov 6, 2026 | |
| ENOV Enovis | Reiterated: Buy | $36 → $42 | $27.16 | +54.64% | 9 | Nov 5, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $19 → $20 | $11.19 | +78.73% | 3 | Nov 5, 2026 | |
| ORGO Organogenesis Holdings | Reiterated: Hold | n/a | $0.8132 | - | 67 | Nov 5, 2026 | |
| VCEL Vericel | Reiterated: Hold | n/a | $54.62 | - | 84 | Nov 5, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | n/a | $20.62 | - | 33 | Nov 4, 2026 | |
| SNN Smith & Nephew | Reiterated: Hold | n/a | $31.15 | - | 3 | Nov 4, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | n/a | $105.59 | - | 69 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.54 | - | 42 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $26.03 | +19.09% | 51 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $316 → $304 | $325.87 | -6.71% | 85 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $234 | $224.41 | +4.27% | 86 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $31.76 | -5.54% | 73 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.42 | - | 64 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $454 | $452.80 | +0.27% | 67 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $58.54 | +7.62% | 1 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $14.52 | +65.29% | 12 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 | $79.41 | +20.89% | 1 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $75 | $82.38 | -8.96% | 44 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $99 | $101.80 | -2.75% | 52 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $14.93 | +40.66% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $71.05 | - | 76 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $10 | $5.45 | +83.49% | 24 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.4482 | +346.23% | 34 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.21 | - | 55 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $319.21 | - | 59 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $1.49 | +168.46% | 13 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $1 | $0.2894 | +245.54% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 75.42 | CHF 61.30 | +23.03% | 64 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0015 | - | 23 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.03 | n/a | 31 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.87 | n/a | 36 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $90.22 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $50.02 | n/a | 31 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $146.51 | n/a | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $323.24 | n/a | 1 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.25 | n/a | 19 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.25 | n/a | 12 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $109.93 | n/a | 2 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.925 | n/a | 10 | Dec 24, 2018 |
AVITA Medical
Nov 6, 2026
Reiterated: Buy
Price Target: $15 → $21
Current: $16.59
Upside: +26.58%
Shoulder Innovations
Nov 6, 2026
Reiterated: Buy
Price Target: $27
Current: $20.54
Upside: +31.45%
Solventum
Nov 6, 2026
Reiterated: Buy
Price Target: $95 → $100
Current: $90.38
Upside: +10.64%
Enovis
Nov 5, 2026
Reiterated: Buy
Price Target: $36 → $42
Current: $27.16
Upside: +54.64%
Mobia Medical
Nov 5, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $11.19
Upside: +78.73%
Organogenesis Holdings
Nov 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.8132
Upside: -
Vericel
Nov 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $54.62
Upside: -
PROCEPT BioRobotics
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.62
Upside: -
Smith & Nephew
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $31.15
Upside: -
Zimmer Biomet Holdings
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $105.59
Upside: -
Nov 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.54
Upside: -
Nov 2, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $26.03
Upside: +19.09%
Oct 29, 2026
Reiterated: Buy
Price Target: $316 → $304
Current: $325.87
Upside: -6.71%
Oct 28, 2026
Reiterated: Buy
Price Target: $205 → $234
Current: $224.41
Upside: +4.27%
Oct 28, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $31.76
Upside: -5.54%
Oct 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.42
Upside: -
Oct 20, 2026
Reiterated: Buy
Price Target: $454
Current: $452.80
Upside: +0.27%
Oct 12, 2026
Reiterated: Buy
Price Target: $63
Current: $58.54
Upside: +7.62%
Oct 12, 2026
Reiterated: Buy
Price Target: $23 → $24
Current: $14.52
Upside: +65.29%
Oct 12, 2026
Reiterated: Buy
Price Target: $96
Current: $79.41
Upside: +20.89%
Oct 12, 2026
Reiterated: Buy
Price Target: $79 → $75
Current: $82.38
Upside: -8.96%
Oct 12, 2026
Reiterated: Buy
Price Target: $100 → $99
Current: $101.80
Upside: -2.75%
Oct 9, 2026
Reiterated: Buy
Price Target: $21
Current: $14.93
Upside: +40.66%
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $71.05
Upside: -
Aug 20, 2026
Rated: Buy
Price Target: $7 → $10
Current: $5.45
Upside: +83.49%
Jul 28, 2026
Reiterated: Buy
Price Target: $2
Current: $0.4482
Upside: +346.23%
Jul 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $25.21
Upside: -
Jul 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $319.21
Upside: -
May 26, 2026
Reiterated: Buy
Price Target: $3 → $4
Current: $1.49
Upside: +168.46%
Mar 31, 2026
Reiterated: Buy
Price Target: $1.5 → $1
Current: $0.2894
Upside: +245.54%
Mar 23, 2026
Reiterated: Buy
Price Target: CHF 75.42
Current: CHF 61.30
Upside: +23.03%
Nov 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0015
Upside: -
Nov 7, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.03
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.87
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $132
Current: $90.22
Upside: n/a
Aug 18, 2023
Rated: Hold
Price Target: n/a
Current: $50.02
Upside: n/a
Apr 17, 2023
Reiterated: Buy
Price Target: $350
Current: $146.51
Upside: n/a
Apr 10, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $323.24
Upside: n/a
Oct 14, 2022
Rated: Hold
Price Target: n/a
Current: $14.25
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $7.25
Upside: n/a
Aug 27, 2020
Rated: Hold
Price Target: n/a
Current: $109.93
Upside: n/a
Dec 24, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.925
Upside: n/a